What is the toxic dose of acetaminophen (paracetamol)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Toxic Dose of Paracetamol

In acute single ingestions, hepatotoxicity risk begins at approximately 7.5 g or 140-150 mg/kg in adults, with serious toxicity typically occurring after ingestion of ≥10 g or ≥200 mg/kg (whichever is less). 1, 2

Acute Single Ingestion Thresholds

The toxic dose varies by clinical context and patient age:

Adults and Children ≥6 Years

  • Emergency department referral threshold: ≥10 g or ≥200 mg/kg (whichever is lower) 2, 3
  • Minimum dose for hepatotoxicity concern: Approximately 7.5 g or 140 mg/kg 1, 4
  • Typical toxic dose: Most adults require ingestion of ≥12 g before serious hepatotoxicity risk becomes significant 5

Children <6 Years

  • Referral threshold: ≥200 mg/kg 2, 3
  • Can observe at home: If dose is definitively <200 mg/kg 2
  • Important caveat: Children under 10-12 years demonstrate lesser hepatotoxicity and only minor transaminase elevations compared to adults, even with overdoses 6

Repeated Supratherapeutic Ingestion (RSTI)

This pattern involves multiple ingestions over >8 hours resulting in cumulative doses >4 g per 24 hours. RSTI carries worse prognosis than acute overdose and requires different thresholds 1:

Referral Criteria for RSTI

Children <6 years - refer if any of the following 2, 3:

  • ≥200 mg/kg over single 24-hour period
  • ≥150 mg/kg per 24 hours for preceding 48 hours
  • ≥100 mg/kg per 24 hours for ≥72 hours

Patients ≥6 years - refer if 2, 3:

  • ≥10 g or ≥200 mg/kg (whichever is less) over single 24-hour period
  • ≥6 g or ≥150 mg/kg (whichever is less) per 24 hours for preceding 48 hours
  • ≥4 g or ≥100 mg/kg (whichever is less) per day for patients with increased susceptibility (chronic alcohol use, isoniazid therapy, prolonged fasting) 2

Evidence for RSTI Toxicity

The Daly et al. study 1 demonstrated that patients with RSTI who developed severe hepatotoxicity (AST >1,000 IU/L) had mean dosing of 12.6 g/day over median 72 hours, with 14% mortality and one requiring transplant. Even patients with moderate hepatotoxicity (AST 50-1,000 IU/L) averaged 12 g/day over 72 hours, with 15% progressing to severe hepatotoxicity and 2% mortality.

Maximum Therapeutic Dose (FDA Label)

The FDA-approved maximum is 4 g (4,000 mg) per 24 hours for adults 7. The label explicitly warns that severe liver damage may occur if taking:

  • More than the maximum daily amount
  • With other acetaminophen-containing products
  • With ≥3 alcoholic drinks daily 7

Risk Stratification Using the Rumack-Matthew Nomogram

For acute ingestions with known time, serum acetaminophen concentration measured 4-24 hours post-ingestion can be plotted on the nomogram 1:

  • No risk zone: No hepatotoxicity expected (0.3% hepatotoxicity, no mortality) 1
  • Possible risk zone: 4.5-5% severe hepatotoxicity risk 1
  • Probable risk zone: 7-10% hepatotoxicity if treated <10 hours; 27-29% if treated 10-24 hours 1
  • High risk zone: 4.2% severe hepatotoxicity if treated <10 hours; 32% if treated 10-24 hours 1

Special Populations and Situations

Massive Overdoses

Ingestions ≥30 g or ≥500 mg/kg require increased acetylcysteine dosing 8. Concentrations more than double the nomogram line indicate massive overdose requiring augmented treatment 8.

Extended-Release Formulations

Any potentially toxic modified-release ingestion (≥10 g or ≥200 mg/kg, whichever is less) should receive full acetylcysteine course 8. Absorption is prolonged but elimination half-life remains similar to immediate-release 1.

Patients with Low Serum Concentrations

Recent evidence shows patients with acetaminophen levels <150 µg/ml are at very low risk of hepatotoxicity, even with other risk factors present 9. No hepatotoxicity developed in 103 patients with levels <150 µg/ml, including those with multiple product ingestion 9.

Critical Pitfalls to Avoid

  1. Do not rely on patient-reported dosing: Histories regarding time and amount are usually unreliable 5
  2. Do not assume alcohol increases toxicity: Contrary to older beliefs, alcohol consumed simultaneously with overdose is actually hepatoprotective, and chronic alcoholics should be managed identically to non-drinkers 6
  3. Do not delay treatment: All 11 deaths in one major study occurred in probable-risk patients treated >10 hours post-ingestion 1
  4. Do not miss delayed presentations: Patients can present in liver failure days after ingestion with undetectable serum acetaminophen concentrations 5
  5. Do not use the nomogram for RSTI or unknown timing: The nomogram only applies to acute single ingestions with known time 1

Related Questions

What is the toxic dose of acetaminophen (paracetamol) for adults and children?
How should I manage a patient with an acetaminophen (paracetamol) level of 76 µg/mL?
What are the stages of acetaminophen toxicity?
In a 78‑kg patient with no risk factors who ingested 5 g of paracetamol (acetaminophen) over a single 24‑hour period, what is the risk of acute toxicity and what management is recommended?
How should an 18-year-old male who ingested 12 g of acetaminophen (paracetamol) over 14 hours be managed?
What are the differential diagnoses for a burning sensation of the tongue?
What is the recommended starting dose and titration schedule of atorvastatin for primary and secondary prevention in adults, including adjustments for patients over 75 years or with hepatic impairment?
How is frozen shoulder graded based on duration stages and severity of motion loss?
What is the recommended initial treatment for a patient aged 50 years or older with suspected giant cell arteritis presenting with new‑onset headache, scalp tenderness, jaw claudication, visual symptoms, and markedly elevated erythrocyte sedimentation rate or C‑reactive protein?
What are the mechanism of action and adverse effects of tirzepatide in an adult with type 2 diabetes who has no personal or family history of medullary thyroid carcinoma, no MEN 2, is not pregnant or breastfeeding, and has no severe hypersensitivity to the drug?
What are the cause, pathophysiology, and treatment of biotinidase deficiency in a 6‑week‑old infant, and can a diagram of the disrupted metabolic pathway be provided?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.